Advertisement

Research Article Free access | 10.1172/JCI116226

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.

S Del Prato, R C Bonadonna, E Bonora, G Gulli, A Solini, M Shank, and R A DeFronzo

Division of Diabetes, University of Texas Health Science Center, San Antonio.

Find articles by Del Prato, S. in: JCI | PubMed | Google Scholar

Division of Diabetes, University of Texas Health Science Center, San Antonio.

Find articles by Bonadonna, R. in: JCI | PubMed | Google Scholar

Division of Diabetes, University of Texas Health Science Center, San Antonio.

Find articles by Bonora, E. in: JCI | PubMed | Google Scholar

Division of Diabetes, University of Texas Health Science Center, San Antonio.

Find articles by Gulli, G. in: JCI | PubMed | Google Scholar

Division of Diabetes, University of Texas Health Science Center, San Antonio.

Find articles by Solini, A. in: JCI | PubMed | Google Scholar

Division of Diabetes, University of Texas Health Science Center, San Antonio.

Find articles by Shank, M. in: JCI | PubMed | Google Scholar

Division of Diabetes, University of Texas Health Science Center, San Antonio.

Find articles by DeFronzo, R. in: JCI | PubMed | Google Scholar

Published February 1, 1993 - More info

Published in Volume 91, Issue 2 on February 1, 1993
J Clin Invest. 1993;91(2):484–494. https://doi.org/10.1172/JCI116226.
© 1993 The American Society for Clinical Investigation
Published February 1, 1993 - Version history
View PDF
Abstract

Seven non-insulin-dependent diabetes mellitus (NIDDM) patients participated in three clamp studies performed with [3-3H]- and [U-14C]glucose and indirect calorimetry: study I, euglycemic (5.2 +/- 0.1 mM) insulin (269 +/- 39 pM) clamp; study II, hyperglycemic (14.9 +/- 1.2 mM) insulin (259 +/- 19 pM) clamp; study III, euglycemic (5.5 +/- 0.3 mM) hyperinsulinemic (1650 +/- 529 pM) clamp. Seven control subjects received a euglycemic (5.1 +/- 0.2 mM) insulin (258 +/- 24 pM) clamp. Glycolysis and glucose oxidation were quantitated from the rate of appearance of 3H2O and 14CO2; glycogen synthesis was calculated as the difference between body glucose disposal and glycolysis. In study I, glucose uptake was decreased by 54% in NIDDM vs. controls. Glycolysis, glycogen synthesis, and glucose oxidation were reduced in NIDDM patients (P < 0.05-0.001). Nonoxidative glycolysis and lipid oxidation were higher. In studies II and III, glucose uptake in NIDDM was equal to controls (40.7 +/- 2.1 and 40.7 +/- 1.7 mumol/min.kg fat-free mass, respectively). In study II, glycolysis, but not glucose oxidation, was normal (P < 0.01 vs. controls). Nonoxidative glycolysis remained higher (P < 0.05). Glycogen deposition increased (P < 0.05 vs. study I), and lipid oxidation remained higher (P < 0.01). In study III, hyperinsulinemia normalized glycogen formation, glycolysis, and lipid oxidation but did not normalize the elevated nonoxidative glycolysis or the decreased glucose oxidation. Lipid oxidation and glycolysis (r = -0.65; P < 0.01), and glucose oxidation (r = -0.75; P < 0.01) were inversely correlated. In conclusion, in NIDDM: (a) insulin resistance involves glycolysis, glycogen synthesis, and glucose oxidation; (b) hyperglycemia and hyperinsulinemia can normalize total body glucose uptake; (c) marked hyperinsulinemia normalizes glycogen synthesis and total flux through glycolysis, but does not restore a normal distribution between oxidation and nonoxidative glycolysis; (d) hyperglycemia cannot overcome the defects in glucose oxidation and nonoxidative glycolysis; (e) lipid oxidation is elevated and is suppressed only with hyperinsulinemia.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (February 1, 1993): No description
Advertisement
Advertisement